[Federal Register Volume 63, Number 216 (Monday, November 9, 1998)]
[Notices]
[Pages 60362-60363]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-29984]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Meeting of the Cancer Advisory Panel for Complementary and
Alternative Medicine
Notice is hereby given of the first meeting of the Cancer Advisory
Panel for Complementary and Alternative Medicine (CAP), November 16,
1998, at the DoubleTree Hotel, 1750 Rockville Pike, Rockville, Maryland
20852. The meeting is scheduled from 8:30 am to 5 pm and is open to the
public. Attendance by the public will be limited to space available.
The Panel's primary responsibility is to provide expert review and
evaluation of summaries of evidence for complementary and alternative
medicine cancer claims by practitioners. The information compiled and
evaluated by each member of the Panel will be provided to the Office of
Alternative Medicine's chartered Alternative Medicine Program Advisory
[[Page 60363]]
Council (AMPAC) to be used during its deliberations.
The agenda includes: (1) An overview of the structure and role of
the CAP; (2) a presentation on the National Cancer Institute-funded
research mechanism; (3) an overview of current Office of Alternative
Medicine (OAM) projects; (4) a discussion of potential future cancer
clinical trials initiatives related to complementary and alternative
medicine; and (5) a public comment session.
The public comment session is scheduled from 3 p.m. to 5 p.m. Each
speaker will be permitted 5 minutes for their presentation. Interested
individuals and representatives of organizations are requested to
notify D. Geoffrey Cheung, Office of Alternative Medicine, NIH, 31
Center Drive, (MSC 2182), Building 31, Room 5B37, Bethesda, MD 20892,
(301) 594-2013, FAX: (301) 594-6757. Letters of intent to present
comments, along with a brief description of the organization
represented, should be received no later than 5:00 p.m. on Thursday,
November 12. Only one representative of an organization may present
oral comments. Any person attending the meeting who does not request an
opportunity to speak in advance of the meeting may be considered for
oral presentation, if time permits, and at the discretion of the
Chairperson. In addition, written comments may be submitted to Dr.
Geoffry Cheung at the address listed above up to ten days following the
meeting.
For additional information please contact Ms. Odessa Colvin,
Program Assistant, OAM, 31 Center Drive, MSC 2182, Building 31, Room
5B37, Bethesda, Maryland, 20892, (301-435-5175). Individuals who plan
to attend and need special assistance, such as sign language
interpretation or other reasonable accommodations, should contact Ms.
Colvin in advance of the meeting.
Dated: November 2, 1998.
Ruth L. Kirschstein,
Deputy Director, National Institute of Health.
[FR Doc. 98-29984 Filed 11-6-98; 8:45 am]
BILLING CODE 4140-01-M
